Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Congress
Main Content

Call for: 2024 Clinical Breakthroughs

For presentation during Plenary Session 4205:
MDS Keynote Lecture and Breakthroughs
08:00 - 10:00, September 30, 2024


Submit a Breakthrough

MDS is seeking proposals or expressions of interest for possible presentation during the MDS Keynote Plenary Session (this session is non-accredited). Clinical Breakthrough Presentations are designed to showcase the results of recent clinical trials or scientific breakthroughs that have major significance for the movement disorders field.  This is a non-accredited session.  

Submit now

Deadline: August 1, 2024 

 

Criteria

Clinical breakthrough abstract submission will be considered for presentation in the 2024 International Congress if they meet the following criteria: 

  • The topic must be critically important to the clinical/scientific community and/or the public. 
  • The proposal should provide results on major phase 2 or phase 3 clinical trials, or novel scientific research. 
  • The proposal must report the main results or outcomes of data or clinical trials that have not been previously presented; major results published or in press but not previously announced or presented at a clinical or scientific meeting will also be considered. 
  • The study and results reported should be novel (not simply an extension of previously published work) or definitively confirm or refute other critically important work. 
     

All accepted proposals must comply with MDS Guidelines, and the final presentations may need to undergo a review process to ensure compliance. 

The following types of studies are NOT appropriate for Clinical Breakthrough Abstract presentations, and will not be considered:  

  • case reports or small series of cases 
  • replication studies 
  • descriptions of study designs or plans with no presentation of data 
  • extensions of previously reported studies 
  • qualitative surveys 
  • reviews of existing treatments 
  • practice reviews 
  • rating scale validation 
  • research proposals 

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice